Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
about
Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particlesRational drug design applied to myeloperoxidase inhibition.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studiesInhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium.How can we prevent cardiovascular disease in diabetes.LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.Peptide 19 of Porphyromonas gingivalis Heat Shock Protein Is a Potent Inducer of Low-Density Lipoprotein Oxidation.Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding.Hydrogen sulfide destroys lipid hydroperoxides in oxidized LDL.Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress.Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.Polyphenols
P2860
Q27317203-082DBD4A-6415-4D18-A7DC-CB45DE2087F7Q30372838-A8D46BD6-0335-4E32-A7CD-C5E1FF4255FDQ33879138-98846FC0-1669-4D22-9A52-73B425B5C576Q34361581-9E7310A4-D4F6-44B8-AA4C-77DF3B1AB5F9Q36625645-B1DFFA39-4FF5-4474-8E27-4269CE16256BQ36776589-D18FB180-DF31-408B-9058-92E1CB5C4322Q36889170-0BE56148-CBF8-449A-AB36-B6D404418F79Q37690728-E0DD9619-CB0D-4CAA-A3E6-00FD620D26A4Q37835617-DEC0DBD0-C9B3-4AAF-AEDA-F284C7E8A15AQ39367439-5138BFDD-695E-4F2E-8AC4-52DF9D62C954Q44440536-DE8B0666-9A85-48C9-983C-91730BAE967FQ46098361-FC7D4944-7D21-431D-A789-63483E8DF262Q46790318-E1E9AA81-2832-4734-8314-CF3519D2AA1EQ53217042-CD37B74F-F78E-4E4F-B165-B7F0241AB69FQ58495805-81FA3519-96BA-4173-8E3E-EF87B3953BA9
P2860
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
@ast
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
@en
type
label
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
@ast
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
@en
prefLabel
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
@ast
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
@en
P2860
P921
P356
P1476
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
@en
P2093
Jay W Heinecke
P2860
P304
P356
10.1084/JEM.20060218
P407
P577
2006-04-10T00:00:00Z
2006-04-17T00:00:00Z